Rational design, preclinical characterization and stability studies of cpHER2_31, a small cyclic peptide for HER2-targeted anticancer applications

Maria Antonietta Occhiuzzi, Elisabetta Pingitore, Martina Chieffallo, Marco Fiorillo, Michele De Luca, Giuseppina Ioele, Antonio Garofalo, Sebastiano Andò, Bruno Rizzuti, Enrico Iaccino, Fedora Grande
European Journal of Medicinal Chemistry Reports · Elsevier · 2026-12-01 · DOI: 10.1016/j.ejmcr.2026.100385

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles